Form 4 for ANTX AN2 Therapeutics, Inc.
Accepted 2022-11-02 00:00:00 ET · period of report 2022-10-31 · accession 0000899243-22-034840 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-11-02 | 2022-10-31+ | ANTX | Easom Eric | CEO, Dir | S - Sale | $15.27 | -4,232 | 4,907 | -46% | -$64.6K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-31 | S | D | 2,688 | $15.39 | 6,451 | D | — | — | |
| 2 | Common | Common Stock | 2022-11-02 | S | D | 1,544 | $15.07 | 4,907 | D | — | — |